Screener
Cullinan Therapeutics, Inc. CGEM Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Cullinan Therapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Cullinan Therapeutics, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 7:10 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336717
FAQ
- What is Cullinan Therapeutics, Inc.'s current ratio?
- Cullinan Therapeutics, Inc. (CGEM) reported current ratio of 8.4× in Q2 2026.
- How has Cullinan Therapeutics, Inc.'s current ratio changed year-over-year?
- Cullinan Therapeutics, Inc.'s current ratio decreased by 14.4% year-over-year, from 9.8× to 8.4×.
- What is the long-term trend for Cullinan Therapeutics, Inc.'s current ratio?
- Over 5 years (2020 to 2025), Cullinan Therapeutics, Inc.'s current ratio has grown at a -7.1% compound annual growth rate (CAGR), from 14.8× to 10.2×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.
Ask your AI about Cullinan Therapeutics, Inc.'s current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude